GGrantIndex
Sort

40,608 grants matching prostate cancer

Elucidating the Molecular Role of SYNCRIP in Prostate Cancer and AR Targeted Therapy Resistance

$408,360
Ping Mu · Ut Southwestern Medical Center · R37 · FY2022 · CA

Defining and Targeting Lineage Transition Programs Operative in AR Pathway Independent Prostate Cancer

$408,336
Peter S Nelson · Fred Hutchinson Cancer Research Center · R01 · FY2021 · CA

Validation, Calibration, and Translation of Restriction Spectrum Imaging Signal Maps to enhance MRI diagnostic capabilities in Prostate Cancer

$408,291
Michael Andre Liss · University Of California, San Diego · R01 · FY2024 · CA

Erythropoietin Blockade for the Treatment of Cancer

$408,266
C. Anthony Blau · University Of Washington · R01 · FY2009 · CA

Designing Magnetic Resonance Protein-based Contrast Agents with High Relaxivity

$408,245
Jenny J Yang · Georgia State University · R01 · FY2013 · EB

Engineering Large Chromosomal Deletions in Mice to Advance Precision Oncology

$408,210
Ming Hui Chen · Duke University · R01 · FY2023 · CA

GENETIC STUDIES OF GOOD HEALTH IN AN AGING TWIN COHORT

$408,170
Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2002 · AG

Prostatectomy vs watchful waiting - a randomized trial.

$408,077
Karolinska Institute · R01 · FY2005 · CA

The structural and functional basis of MET exon 14 activation and acquired drug resistance

$408,060
Natalia Jura · University Of California, San Francisco · R01 · FY2019 · CA

Cancer-prone cell states of the fallopian tubal epithelium

$408,037
Alexander Y Nikitin · Cornell University · R01 · FY2024 · CA

Defining and Targeting Lineage Transition Programs Operative in AR Pathway Independent Prostate Cancer

$408,005
Peter S Nelson · Fred Hutchinson Cancer Center · R01 · FY2023 · CA

Defining and Targeting Lineage Transition Programs Operative in AR Pathway Independent Prostate Cancer

$408,005
Peter S Nelson · Fred Hutchinson Cancer Center · R01 · FY2022 · CA

Dissecting and Predicting Lethal Prostate Cancer using Biologically Informed Artificial Intelligence

$408,004
Eliezer M Van Allen · Dana-Farber Cancer Inst · P50 · FY2025 · CA

A Multiethnic Genome-Wide Scan of Prostate Cancer

$408,000
Christopher Alan Haiman · University Of Southern California · U01 · FY2009 · HG

PLCO EEMS and Extended Follow Up

$407,995
Neal Freedman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA

Elucidating the Molecular Role of SYNCRIP in Prostate Cancer and AR Targeted Therapy Resistance

$407,945
Ping Mu · Ut Southwestern Medical Center · R37 · FY2021 · CA

METABOLIC IMAGING OF THE PROSTATE USING 3-D MRSI

$407,934
Daniel B Vigneron · University Of California, San Francisco · R01 · FY2007 · CA

Proteases in Prostate Cancer Bone Metastasis

$407,908
Wayne State University · R01 · FY2005 · DK

Virtual Conversations for Prostate Cancer Decisions

$407,833
William Glenn Harless · Interactive Drama, Inc. · R44 · FY2009 · CA

METABOLIC REPROGRAMMING OF PROSTATE CANCER AND ANTITUMOR IMMUNITY BY TARGETING LDH-A

$407,718
Beth Israel Deaconess Medical Center, Inc. · · FY2015 · Department of Defense

The Role of miRNA-mediated RNAI in the Biology of Cancer

$407,712
Natasha Caplen · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Genetic and Molecular Basis of Rapamycin Sensitivity

$407,685
Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2004 · CA

2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership

$407,680
Roberta M Troy · Tuskegee University · U54 · FY2017 · CA

Leveraging Tumor Suppressor Inactivation for Osteosarcoma Therapy

$407,660
Bang H Hoang · Albert Einstein College Of Medicine · R01 · FY2022 · CA

The Role of CXCL12 Signaling in Obesity-Induced Prostate Cancer Progression

$407,569
John Digiovanni · University Of Texas At Austin · R01 · FY2015 · CA